This paper examines issues related to private health insurance exchanges, possible structures of an exchange, funding, as well as the pros, cons, and uncertainties to employers of adopting them. A summary of recent surveys on employer attitudes are examined, as are some changes that employers...

The Canada Health Act (CHA) creates a series of “grey zones” in which considerable discretion is granted to the federal health minister to determine what is subject to penalty under the Act. This report outlines the provisions of the CHA, and examines four current issues relating to the Act:...

The Mexican health system has evolved through three generations of reform. The creation of the Ministry of Health and the main social security agency in 1943 marked the first generation of health reforms. In the late 1970s, a second generation of reforms was launched around the primary...

The present paper discusses two of the most relevant principles of the paradigm of Justice within the debate regarding the allocation of public resources to health policies: the principles of equality and equity. It emphasizes the need for transparency concerning public policies, since...

This paper examines the recent WTO Panel Report in US- Clove Cigarettes within the context of the other two ongoing WTO disputes concerning US measures under the WTO's Agreement on Technical Barriers to Trade. Appeals in two of the cases are underway and the third is anticipated, providing the...

The Article explores the nation’s resistance to developing a more equitable system of health care coverage. It does that through reference to the nation’s peculiar class system. Americans contend that anyone can avoid poverty through hard work and responsible choices. Yet, in fact, class...

We propose a triple test to evaluate the usefulness of behavioral economics models for public health policy. Test 1 is whether the model provides reasonably new insights. Test 2 is on whether these have been properly applied to policy settings. Test 3 is whether they are corroborated by...

This paper analyzes a maximum price system and a reference price system in a vertical differentiation model with a brand-name drug and a generic. In particular, both instruments are compared with respect to their performance in reducing public expenditure, limiting financial exposure of...